Industries > Pharma > Vaccine Sales Market Report 2023-2033

Vaccine Sales Market Report 2023-2033

Forecasts by Type (Inactivated, Live Attenuated, Toxoid, Recombinant/Conjugate/Subunit), by Application (Pneumococcal, Influenza, Hepatitis, Meningococcal, COVID-19, Others), by Route of Administration (Intramuscular, Subcutaneous, Oral), by Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, Others), by Age Group (Paediatrics, Adults) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

PUBLISHED: 27 June 2023
PAGES: 364
PRODUCT CODE: PHA1259
SUBMARKET: Contract Services

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA1259 Categories: , Tags: , , , , ,

The Vaccine Sales Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Investment in the Development of Vaccines to Boost Industry Growth
The growing attention towards vaccine research is attributed to the significant advancements in the domains of microbial pathogenesis and immunology. These developments have facilitated researchers and developers in devising preventive and therapeutic vaccines, as well as targeting novel diseases that were previously deemed unfeasible. Apart from the scientific progress, the current expansion of the worldwide vaccine market and the potential to attain “blockbuster” status by generating substantial sales revenue have motivated vaccine producers to revitalise and/or broaden their research endeavours. This is aimed at enhancing the public health impact while also achieving commercial success.

What Questions Should You Ask before Buying a Market Research Report?
• How is the vaccine sales market evolving?
• What is driving and restraining the vaccine sales market?
• How will each vaccine sales submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each vaccine sales submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading vaccine sales markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the vaccine sales projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of
vaccine sales projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the vaccine sales market?
• Where is the vaccine sales market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the vaccine sales market today, and over the next 10 years:
• Our 364-page report provides 140 tables and 199 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the vaccine sales market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Type
• Inactivated
• Live Attenuated
• Toxoid
• Recombinant/Conjugate/Subunit

Application
• Pneumococcal
• Influenza
• Hepatitis
• Meningococcal
• COVID-19
• Others

Route of Administration
• Intramuscular
• Subcutaneous
• Oral

Distribution Channel
• Hospital & Retail Pharmacies
• Government Suppliers
• Others

Age Group
• Paediatrics
• Adults

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• South-East Asia
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

Vaccine Sales Market Report 2023-2033
Need industry data? Please contact us today.

The report also includes profiles and for some of the leading companies in the Vaccine Sales Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• AstraZeneca
• Bavarian Nordic
• Bharat Biotech
• CSL
• Daiichi Sankyo, Inc.
• Emergent BioSolutions Inc.
• GSK plc
• INOVIO Pharmaceuticals
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.
• Mitsubishi Tanabe Pharma Corporation
• Moderna, Inc.
• Novavax
• Panacea Biotec
• Pfizer Inc.
• Sanofi
• Serum Institute of India Pvt. Ltd.
• Sinopharm
• SINOVAC
• Takeda Pharmaceutical Company Limited

Overall world revenue for Vaccine Sales Market, 2023 to 2033 in terms of value the market will surpass US$120 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Vaccine Sales Market, 2023 to 2033 report help you?
In summary, our 360+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Vaccine Sales Market, 2023 to 2033 Market, with forecasts for type, application, route of administration, distribution channel, and age group, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 22 key national markets – See forecasts for the Vaccine Sales Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 20 of the major companies involved in the Vaccine Sales Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Vaccine Sales Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Vaccine Sales Market Report 2023-2033: Forecasts by Type (Inactivated, Live Attenuated, Toxoid, Recombinant/Conjugate/Subunit), by Application (Pneumococcal, Influenza, Hepatitis, Meningococcal, COVID-19, Others), by Route of Administration (Intramuscular, Subcutaneous, Oral), by Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, Others), by Age Group (Paediatrics, Adults) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Vaccine Sales Market Report 2023-2033

    Download sample pages

    Complete the form below to download your free sample pages for Vaccine Sales Market Report 2023-2033

      Latest Pharma news

      Cell & Gene Therapy Cold Chain Logistics Market

      The global Cell and Gene Therapy Cold Chain Logistics market is projected to grow at a CAGR of 15.5% by 2034

      19 June 2024

      READ

      Cancer Immunotherapy Market

      The global Cancer Immunotherapy market is projected to grow at a CAGR of 12.6% by 2034

      11 June 2024

      READ

      Biological Safety Testing Market

      The global Biological Safety Testing market is projected to grow at a CAGR of 12.6% by 2034

      11 June 2024

      READ

      CAR-T Therapy Market

      The global CAR-T Therapy market is projected to grow at a CAGR of 35.9% by 2034

      11 June 2024

      READ